PRP and MFAT combination therapy is a regenerative orthopedic treatment that blends platelet-rich plasma (PRP) from your blood with microfragmented adipose tissue (MFAT) from your fat to repair advanced joint damage, chronic tendon injuries, and osteoarthritis. The two biologics play different roles: MFAT delivers living regenerative cells that cushion the joint and rebuild tissue, while PRP delivers concentrated growth factors that amplify the repair signal. Together, they create a stronger and longer-lasting healing environment than either treatment produces on its own.
In this article, we explain what each biologic contributes, how the two work together at the cellular level, what happens during the procedure, who makes a good candidate, what the clinical research shows, and what to expect during recovery.
What Is PRP and MFAT Combination Therapy?
PRP and MFAT combination therapy is a dual regenerative treatment that pairs two biologics harvested from your own body: concentrated platelets from your blood and microfragmented fat tissue from your abdomen or lower back. Both materials are autologous, meaning they come from you, which keeps the risk of rejection or allergic reaction extremely low. The pairing exists because joint damage involves two separate problems at once: the tissue needs new repair cells, and those repair cells need a strong signal telling them what to rebuild. Combination therapy addresses both problems in a single treatment plan.
The demand for this kind of biologic approach reflects the scale of the underlying problem. Osteoarthritis affects more than 250 million people worldwide and ranks as the fourth leading cause of disability in men, according to research published in the Journal of Clinical Medicine. In the United States, the Centers for Disease Control and Prevention (CDC) reports that 1 in 4 adults has arthritis, a figure projected to reach 78 million by 2040. For joints that have degenerated past the point where a single biologic can turn things around, the combined approach gives the tissue both the cells and the signal it needs.
What Is the Difference Between PRP and MFAT?
The difference between PRP and MFAT is that PRP delivers growth factor proteins from your blood, while MFAT delivers living regenerative cells from your fat tissue. PRP therapy concentrates platelets, the blood cells that store repair proteins including platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-B), vascular endothelial growth factor (VEGF), and epidermal growth factor (EGF), according to research published in Blood Research. Platelets carry powerful signals, but platelets are not cells, and signals alone cannot rebuild what advanced degeneration has destroyed.
MFAT supplies what platelets cannot. Fat tissue, known medically as adipose tissue, holds the highest concentration of mesenchymal stromal cells (MSCs) of any tissue in the body: up to 2% of the cells in microfragmented fat are MSCs, compared with roughly 0.02% in bone marrow, per the Journal of Clinical Medicine study. Mesenchymal cells are living, multipotent cells that can differentiate into chondrocytes, the cells that maintain cartilage. These cells even, at times, donate their mitochondria, their energy-producing machinery, to struggling chondrocytes inside a damaged joint. MFAT injections also carry anti-inflammatory cytokines and a structural matrix that cushions the joint. The table below summarizes how the two biologics compare, and what the combination adds.
| Factor | PRP | MFAT | PRP + MFAT Combined |
|---|---|---|---|
| Source | Your blood | Your fat tissue | Both |
| Active component | Platelets and growth factor proteins | Mesenchymal cells, cytokines, structural matrix | Repair cells plus an amplified growth factor signal |
| Primary role | Signals and accelerates repair | Rebuilds, cushions, and regulates inflammation | A longer-lasting restorative environment |
| Best suited for | Early to moderate injuries and degeneration | Moderate to advanced joint damage | Advanced degeneration and stubborn combined injuries |
| Harvest method | Standard blood draw | Mini liposuction under local anesthetic | Blood draw plus mini liposuction |
Two materials with two different jobs raise the natural next question: what actually happens when they are placed in the same joint?
How Do PRP and MFAT Work Together?
PRP and MFAT work together by pairing a cellular scaffold with an amplified repair signal: the MFAT matrix delivers regenerative cells and cushioning to the damaged tissue, while the PRP floods that same tissue with growth factors that direct and accelerate the rebuilding. Researchers describe the relationship as synergistic. The platelet granules in PRP secrete complementary and, in some cases, identical anti-inflammatory and pro-regenerative molecules, such as PDGF and FGF-2, that enhance the paracrine activity of the fat graft, meaning the MFAT cells communicate and coordinate repair more effectively with the platelet signal present, according to the Journal of Clinical Medicine study.
The coordination happens on both sides. The mesenchymal cells inside MFAT act as microenvironment sensors, detecting the state of the damaged tissue and releasing growth factors and cytokines with anti-inflammatory, blood-vessel-forming, and regenerative effects exactly where they are needed. The platelet payload, in turn, may extend how long the fat graft keeps releasing those healing factors. One biologic sustains the repair crew; the other keeps handing it instructions. Delivering both to the joint requires a procedure with a few more steps than a standard injection.
What Is the PRP and MFAT Procedure Like?
The PRP and MFAT procedure involves four stages: a fat harvest, MFAT processing, PRP preparation from a blood draw, and ultrasound-guided injection into the damaged joint or tissue. The MFAT session generally takes 1 to 2 hours, and patients return home the same day. There is no sedation, so you can drive yourself home afterward.
- Fat harvest. Using minimally invasive liposuction under local anesthetic, we remove a small amount of fat tissue from the lower back or belly, areas where accessible adipose tissue is usually abundant.
- MFAT processing. The harvested fat is washed and mechanically microfragmented, reducing the clusters of adipose tissue from 1 to 3.5 millimeters down to 0.2 to 0.8 millimeters, per the published protocol in the Journal of Clinical Medicine. Gentle mechanical processing preserves the living mesenchymal cells and their natural support environment, without harsh enzymes.
- PRP preparation. A small blood sample is drawn and spun in a centrifuge, separating and concentrating the platelets within the plasma.
- Ultrasound-guided injection. The biologics are injected into the damaged joint or tissue under ultrasound imaging, which places the material precisely where the injury sits.
At our clinic, the two biologics are staged rather than delivered all at once. The MFAT injection comes first, sending the regenerative cells to the damaged area. A few weeks later, we inject the PRP to accelerate the healing that the fat graft has started. Staging the injections lets the second biologic reinforce a repair process that is already underway, and both injections are guided with ultrasound for exact placement. Getting the most from those injections starts with how you prepare.
How to Prepare for the Procedure
To prepare for PRP and MFAT combination therapy, stay well hydrated, eat a normal meal beforehand, and pause anti-inflammatory medications and blood thinners as directed by your provider. Hydration and food keep the blood draw comfortable. Pausing nonsteroidal anti-inflammatory drugs (NSAIDs) matters because the treatment deliberately uses a short, controlled inflammatory response to launch healing, and NSAIDs suppress exactly that response. Your provider will also review your health history first, since pregnancy, an active cancer diagnosis, and certain blood or platelet disorders point toward other treatment options instead. That candidacy review deserves a closer look, because the combination is chosen for specific situations.
Who Is a Good Candidate for PRP and MFAT Combination Therapy?
Good candidates for PRP and MFAT combination therapy are people with advanced joint degeneration, persistent tendon or ligament injuries, or arthritis that has not responded to conservative care, who want to avoid or delay surgery. The combination earns its place where a single biologic may not be strong enough. The conditions we treat most often with PRP and MFAT therapy include:
- Bone-on-bone knee arthritis and other advanced osteoarthritis, where the joint needs both cushioning and repair cells
- Chronic meniscal tears that have resisted rest and physical therapy
- Partial rotator cuff injuries and other stubborn tendon damage
- Ligament injuries with ongoing instability or pain
- Athletes and active adults who want to return to sport with as little downtime as possible
Candidacy also includes a practical consideration the research surfaced: body composition. Patients with a low body mass index (BMI) sometimes cannot supply enough fat tissue for a full MFAT treatment on its own. The Journal of Clinical Medicine study specifically noted that adding PRP offsets a smaller fat harvest, letting leaner patients receive the full therapeutic benefit of the combined preparation. At our Tigard clinic, an ultrasound evaluation tells us which structures are damaged, how advanced the degeneration is, and whether the combination, or a single biologic, fits your situation. Whichever profile fits you, the reasonable next question is what the treatment actually achieves.
What Results Can You Expect From Combining PRP and MFAT?
You can expect meaningful pain reduction and improved joint function from combining PRP and MFAT, with 73% of patients responding to the combined treatment in the largest study of its kind. That study, published in the Journal of Clinical Medicine in 2022, followed 147 patients with grade 1 to 4 hip osteoarthritis for one year. In the group receiving MFAT plus PRP, 73% of patients who completed follow-up reported reduced pain, and more than 60% of responders qualified as super-responders, meaning their pain dropped by 20 points or more on the 100-point visual analogue scale (VAS). Joint function improved in parallel: 73% of the functional super-responders gained 8 or more points on the Oxford Hip Score, the threshold researchers consider a clinically important difference.
The evidence extends beyond joints to soft tissue. A 2021 case report documented a 50-year-old patient with a partial-thickness supraspinatus tear, a rotator cuff injury that had failed traditional therapies. After the combined treatment, a follow-up ultrasound at 28 weeks showed full resolution of the tear and near-complete restoration of shoulder mobility. The fat graft supplied the cellular platform for the repair, while the platelets accelerated it with growth factors.
One honest boundary belongs in the picture. The hip study found that once a joint reaches a very advanced state of degeneration and loses its sphericity, its round shape, the likelihood of improvement with biologic therapies diminishes. The researchers’ takeaway was that joints respond best when treated earlier in the arthritis process. Earlier treatment produces stronger results, and the results themselves arrive on a predictable timeline.
How Long Does It Take to See Results?
It takes about 3 to 4 weeks to feel the first improvements from PRP and MFAT combination therapy, and the treated tissue keeps strengthening for up to a year. Healing moves through three phases. The first phase is inflammation, lasting a few days, during which the treated area feels sore and swollen. Inflammation at this stage is commonly misread as a setback; it is actually the mechanism, the body’s signal that healing cells are being recruited to the site. The second phase is proliferation, when new tissue grows over the following weeks and discomfort begins fading. The third phase is remodeling, when the newly built tissue matures and gains strength, a process that can continue for up to a year after treatment.
The staged injection protocol layers onto this timeline naturally. The PRP injection, delivered a few weeks after the MFAT, lands during the proliferative phase, reinforcing the repair right when new tissue formation is at its peak.
What Are the Signs That the Treatment Is Working?
The signs that the treatment is working are steadily decreasing pain from around week 3 onward, easier joint movement, less stiffness after rest, and growing tolerance for activities that used to trigger flare-ups. The improvement builds gradually rather than arriving overnight, which is the expected signature of tissue repair as opposed to a numbing agent. In the one-year hip study, both pain and function scores kept improving across the 3, 6, and 12 month checkpoints. A downward pain trend across months 2 and 3 means the biologics are doing their work, and the durability of that work is the next thing patients ask about.
How Long Do the Results Last?
The results of PRP and MFAT combination therapy last a year or longer, with the published research documenting sustained pain and function improvements through 12 months of follow-up. Durability is the direct product of the mechanism. Because the treatment rebuilds tissue rather than masking symptoms, the relief reflects structural change that remains after the injected biologics themselves are gone. The remodeling phase keeps strengthening the repair through the full first year.
Longevity is also where the combination distinguishes itself from lighter interventions. Standalone PRP already outlasts cortisone, and the adipose graft adds a cellular and structural dimension that growth factors alone do not provide. Some patients pair the plan with hyaluronic acid when the joint also needs immediate lubrication, and patients managing long-term arthritis often return for a maintenance treatment annually rather than restarting from zero. Results this durable are only worth pursuing if the treatment producing them is safe, and the safety record here is strong.
Is PRP and MFAT Combination Therapy Safe?
Yes, PRP and MFAT combination therapy is safe for appropriately selected patients, because both biologics come from your own body, which keeps the risk of rejection or allergic reaction extremely low. The safety record in the published research backs the biology: across all 147 patients in the Journal of Clinical Medicine study, researchers observed zero infections and zero thromboembolic events. The most common issues were temporary joint soreness and soreness at the fat harvest site, both consistent with the inflammation phase of normal healing.
Sterile preparation protocols, single-use equipment, and ultrasound-guided placement manage the small remaining risks. Candidacy screening handles the rest: we recommend other options for patients who are pregnant, have an active cancer diagnosis, or have platelet and clotting disorders that a pre-treatment health review would surface. For everyone else, the main safety variable after the procedure is the one you control: aftercare.
What Should You Do After the Procedure?
After PRP and MFAT combination therapy, rest the treated area for the first few days, avoid anti-inflammatory medications, care for the small fat harvest site as instructed, and rebuild activity gradually with the physical therapy exercises your provider prescribes. The early rest window protects the graft while the biologics settle in and the inflammation phase runs its course. Avoiding NSAIDs preserves that same inflammatory signal the treatment depends on; acetaminophen and ice, used as directed, handle any discomfort without interfering.
Physical therapy exercises carry more weight here than most patients expect. New tissue built during the proliferative phase organizes along the lines of stress placed on it, so a graduated loading program literally shapes a stronger repair. Symptom flare-ups lasting 1 to 3 days after treatment are a normal part of the healing response, after which improvement typically begins. We provide complete post-procedure instructions and follow-up visits at our Tigard office, timing the second-stage PRP injection and tracking the repair as the phases progress. Patients dealing with knee pain in particular tend to see the payoff of disciplined aftercare, since the knee bears load with every step of recovery.
Frequently Asked Questions
How Many Times a Year Should You Do PRP?
Most patients do PRP one to three times a year, depending on the condition, its severity, and how the tissue responds to the first treatment. Within a combination plan, the PRP injection follows the MFAT injection by a few weeks as a single coordinated course, and patients with long-term arthritis often return for one maintenance treatment annually to sustain the gains.
What Kind of Doctor Performs PRP Injections?
PRP injections are performed by physicians trained in regenerative and musculoskeletal medicine, including naturopathic doctors, sports medicine physicians, physiatrists, and orthopedic providers. The credential that matters most in practice is training in ultrasound-guided injection technique, because image guidance is what places the biologic in the exact tissue that needs it.
Can PRP and MFAT Work on a 50 Year Old?
Yes, PRP and MFAT can work on a 50 year old, and on patients well beyond 50, because platelets keep their growth factor content and fat tissue keeps its mesenchymal cell supply throughout adult life. The published case of the fully resolved rotator cuff tear involved a 50-year-old patient, and the mean age in the 147-patient hip study was 60. The condition of the joint matters more than the birth date: earlier-stage degeneration responds better at any age.
Are PRP Injections Worth the Money?
Yes, PRP injections are worth the money for patients whose conditions match the evidence, particularly people who have plateaued with rest, medication, or physical therapy and want to avoid or delay surgery. Nationally, PRP injection use quadrupled between 2010 and 2020 according to a US insurance claims study, growth driven by the durability of results that symptom-masking treatments cannot match. The combination with MFAT extends that value to more advanced joint damage that PRP alone may not fully address.
Can I Drive After a PRP Injection?
Yes, you can drive after a PRP injection, and after the MFAT procedure as well, because both are performed under local anesthetic with no sedation. Most patients return to desk work the same day or the next day. The main restriction is on strenuous loading of the treated joint, not on ordinary daily movement.
Is MFAT Covered by Insurance?
No, MFAT is not covered by insurance, and neither is PRP, because the Food and Drug Administration (FDA) classifies both as investigational treatments, which keeps them outside standard coverage despite their growing use in clinical practice. A consultation is the reliable way to understand what a complete treatment plan would involve for your specific joint and goals.
Putting It All Together
PRP and MFAT combination therapy pairs the two strongest healing resources your own body produces: fat tissue carrying the richest mesenchymal cell supply in the body, and platelets carrying the growth factors that direct repair. MFAT rebuilds and cushions; PRP signals and accelerates; staged together under ultrasound guidance, they create a restorative environment that published research links to a 73% response rate and pain improvements sustained through a full year. For advanced joint degeneration, stubborn tendon injuries, and arthritis that conservative care never resolved, the combination offers a repair-based path that a single biologic cannot always deliver.
If you are weighing your options for a joint that keeps holding you back, the team at Active Pain Relief is glad to help you sort out whether the combined approach fits your situation. We offer free consultations with ultrasound evaluation, and you can schedule a visit whenever you are ready.
